Skip to main content

Table 2 Predictors of premature discontinuation of aromatase inhibitors

From: Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

 

Univariate analyses

Multivariate analysis

Predictors

HR

95% CI

P-value

HR

95% CI

P-value

Patient-reported worst joint pain

      

0-3

1

  

1

  

4-10

1.86

1.04-3.31

0.037

2.09

1.14-3.80

0.016

Prior tamoxifen use

      

No

1

  

1

  

Yes

1.7

0.94-3.07

0.088

2.01

1.09-3.70

0.026

Education

      

College and above

1

  

1

  

High school or less

0.42

0.17-1.08

0.071

0.37

0.13-1.03

0.057

  1. Abbreviations: HR hazard ratio, 95% CI 95% confidence interval.